Serum Institute of India to acquire 20 percent stake in IntegriMedical

Serum Institute of India (SII) on Friday announced a strategic investment in IntegriMedical, acquiring a 20 percent stake in the company, to advance Needle-Free Injection System technology.

 

According to the company’s statement, the partnership between SII and IntegriMedical aligns with SII’s vision of ‘Health for All’ and IntegriMedical’s mission to ‘Transform Healthcare Globally’ by providing patient comfort, ensuring increased patient compliance, reducing needle-stick injuries, and enhancing the efficacy of liquid medication via needle-free dispersion.

 

IntegriMedical has developed a US patented Needle-Free Injection System (N-FIS) that utilizes high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs. The innovative drug delivery solution aims to alleviate pain during administration, providing needle-phobic patients with a pleasant and stress-free experience, the company claimed.

 

Read more@ https://www.financialexpress.com/business/healthcare-serum-institute-of-india-to-acquire-20-percent-stake-in-integrimedical-3491938/

Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections